The economic impact of the utilization of liver allografts with high donor risk index

American Journal of Transplantation

Volumn 7, Issue 4, 2007, Pages 990-997

  Axelrod, D A ^a   Schnitzler, M ^b   Salvalaggio, P R ^b   Swindle, J ^b   Abecassis, M M ^c  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Donor risk index; Economics; Liver transplant; Marginal donors

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; FEMALE; GRAFT RECIPIENT; HEALTH CARE COST; HIGH RISK POPULATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LINEAR REGRESSION ANALYSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL; MULTIVARIATE ANALYSIS; ORGAN DONOR; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT;

COST OF ILLNESS; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MULTIVARIATE ANALYSIS; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; UNITED STATES;

EID: 33947586729     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01724.x     Document Type: Article

References (26)

1. Axelrod DA, Koffron AJ, Baker T et al. The economic impact of MELD on liver transplant centers. Am J Transplant 2005; 5: 2297-2301.
2. Showstack J, Katz PP, Lake JR et al. Resource utilization in liver transplantation: Effects of patient characteristics and clinical practice. JAMA 1999; 281: 1381-1386.
3. Whiting JF, Martin J, Zavala E, Hanto D. The influence of clinical variables on hospital costs after orthotopic liver transplantation. Surgery 1999; 125: 217-222.
4. Markman JF, Markmann JW, Markman DA et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 2001; 72: 1113-1122.
5. Washburn WK, Pollock BH, Nichols L, Speeg KB, Halff G. Impact of recipient MELD score on resource utilization. Am J Transplant 2006; 6: 2449-2454.
6. Marks WH, Wagner D, Pearson TC et al. Organ donation and utilization, 1995-2004: Entering the collaborative era. Am J Transplant 2006; 6: 1101-1110.
7. www.ustransplant.org. Accessed October 8, 2006.
8. Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
9. Manzarbeitia CY, Ortiz JA, Jeon H et al. Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation 2004; 78: 211-215.
10. Mateo R, Cho Y, Singh G et al. Risk factors for graft survival after liver transplantation after cardiac death donors: An analysis of OPTN/UNOS data. Am J Transplant 2006; 6: 791-796.
11. Doshi MD, Hunsicker LG. Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant 2007; 1: 122-129.
12. Lake JR, Shorr JS, Steffen BJ et al. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C, and without viral hepatitis. Am J Transplant 2005; 5: 549-557.
13. Cameron AM, Ghobrial RM, Yersiz H et al. Optimal utilization of donor grafts with extended criteria: A single-center experience in over 1000 liver transplants. Ann Surg 2006; 243: 748-753.
14. Tector AJ, Mangus RS, Chestovich P et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006; 244: 439-450.
15. Shiffman ML, Saab S, Feng S et al. Liver and intestine transplantation in the United States, 1995-2004. Am J Transplant 2006; 6: 1170-1187.
16. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list: Impact of organ allocation and patient outcomes. JAMA 2004; 291: 1871-1874.
17. Machicao VI, Bonatti H, Krishna M et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004; 77: 84-92.
18. Whiting JF, Woodward RS, Zavala EY et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: Analysis of Medicare payments. Transplantation 2000; 70: 755-760.
19. Schnitzler MA, Whiting JF, Brennan DC et al. The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation 2003; 75: 1940-1945.
20. Sellers MT, Velidedeoglu E, Bloom RD et al. Expanded-criteria donor kidneys: A single-center clinical and short-term financial analysis - cause for concern in retransplantation. Transplantation 2004; 78: 1670-1675.
21. Reed A, Howard RJ, Fujita S et al. Liver retransplantation: A single-center outcome and financial analysis. Transplant Proc 2005; 37: 1161-1163.
22. Azoulay D, Linhares MM, Huguet E et al. Decision for retransplantation of the liver: An experience and cost based analysis. Ann Surg 2002; 236: 713-721.
23. Foley DP, Fernandez LA, Leverson G. Donation after cardiac death: The University of Wisconsin experience with liver transplantation. Ann Surg 2005; 242: 724-731.
24. Merion RM, Rush SH, Dykstra DM et al. Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients. Am J Transplant 2004; 4: 1792-1797.
25. Baker TB, Ahya SN, Abecassis MM. The use of marginal donors is not justified in combined liver/kidney transplantation. Am J Transplant 2006; 6: 273.
26. Abecassis MM. Financial outcomes in transplantation - a provider's perspective. Am J Transplant 2006; 6: 1257-1263.